FOLFOX4 After Surgery Improves Overall Survival In Patients With Early Colon Cancer

Armen Hareyan's picture
Advertisement

FOLFOX4, an Eloxatin (oxaliplatin injection)-based chemotherapy regimen, significantly improved the overall survival of patients with surgically resected

Advertisement